checkAd

    Theraclion  269  0 Kommentare  Half year results 2019 - Seite 2

    06/30/2019

    06/30/2018

    Var. %

    Sales

    963

    862

    +12%

    Subsidies

    338

    6

    +169%

    Other revenue

    15

    0

    n.a.

    Total revenues

    1 316

    868

    +52%

    Cost of Goods Sold

    -527

    -518

    +2%

    External charges

    -1 146

    -2 053

    -44%

    People costs

    -1 667

    -2 084

    -20%

    Other operating costs

    -194

    -389

    -50%

    Total operating costs

    -3 525

    -5 044

    -30%

    EBIT

    -2 218

    -4 176

    +47%

    Financial results

    -87

    -121

    +28%

    Non current results

    -47

    -25

    -88%

    Tax Credit

    680

    710

    -4%

    Net Result

    -1 673

    -3 611

    +54%

     

     

     

    Seite 2 von 4



    Business Wire (engl.)
    0 Follower
    Autor folgen

    Theraclion  Half year results 2019 - Seite 2 Regulatory News: THERACLION (Paris:ALTHE) (ISIN: FR0010120402; Ticker: ALTHE, eligible for the PEA-PME equity investment plan), an innovative company specializing in the development of medical equipment for echotherapy, notably for varicose veins, …